Tarbox Family Office, Inc. Xencor Inc Transaction History

Tarbox Family Office, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$34.33 - $44.68 $1,441 - $1,876	-42 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$36.63 - $47.63 $769 - $1,000	-21 Reduced 33.33%	42 $2,000
Q3 2020 Oct 22, 2020	BUY	$30.09 - $43.02 $631 - $903	21 Added 50.0%	63 $2,000
Q2 2020 Jul 23, 2020	BUY	$27.76 - $33.42 $1,165 - $1,403	42 New	42 $1,000
Q1 2020 Apr 30, 2020	SELL	$20.69 - $37.79 $1,489 - $2,720	-72 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$32.75 - $41.43 $2,358 - $2,982	72 New	72 $2,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.45B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.